Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

SONN

Sonnet BioTherapeutics (SONN)

Sonnet BioTherapeutics Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SONN
DateHeureSourceTitreSymboleSociété
16/04/202515h10GlobeNewswire Inc.Sonnet Releases Virtual Investor "What This Means" SegmentNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
04/04/202515h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
04/04/202515h00GlobeNewswire Inc.Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest DoseNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
01/04/202522h15GlobeNewswire Inc.Sonnet Announces Release of Corporate Update VideoNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
01/04/202513h30GlobeNewswire Inc.Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
26/03/202514h05GlobeNewswire Inc.Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain SarcomasNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/03/202513h50GlobeNewswire Inc.Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant ProteinNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
11/03/202513h45GlobeNewswire Inc.Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
21/02/202522h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
19/02/202514h35GlobeNewswire Inc.Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug CandidatesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
18/02/202515h15GlobeNewswire Inc.Sonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO ConferenceNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
13/02/202522h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
13/02/202514h30GlobeNewswire Inc.Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business OfficerNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
13/02/202514h00GlobeNewswire Inc.Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings UpdateNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
03/02/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
31/01/202522h57Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
30/01/202523h25Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
28/01/202515h05GlobeNewswire Inc.Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform TechnologyNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/01/202522h15Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
22/01/202514h35GlobeNewswire Inc.Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment WebinarNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
21/01/202515h05GlobeNewswire Inc.Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain SarcomasNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
13/01/202522h34Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
23/12/202422h05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
23/12/202415h20GlobeNewswire Inc.Sonnet BioTherapeutics Announces Release of the Next CEO Corner SegmentNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/12/202415h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
17/12/202414h50GlobeNewswire Inc.Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
10/12/202415h20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/12/202421h42GlobeNewswire Inc.Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
09/12/202414h45GlobeNewswire Inc.Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 TrialNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
06/12/202403h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SONNSonnet BioTherapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:SONN